Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)
Compounded drug products should only be used when the needs of patients cannot be met by an FDA-approved drug product
We also accept CIP, CFR, CIF, DDP, DDU etc
Schedule a weight loss consult check out our recent reviews Elite Medical & Aesthetics is a premier med spa located in Lone Tree, CO
Clinicians typically begin with a very low exposure
Studies in mice have also demonstrated that intact GLP-1R signaling within the portal circulation is integral to glucose sensing (63)
